{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:53Z","timestamp":1786649273893,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this review is to demonstrate the safety and procedures involved in the use of intensity-modulated radiation therapy (IMRT) and three-dimensional (3D)-conformal techniques for the management of diffuse choroidal hemangioma (DCH) and to compare dosimetric outcomes of these techniques to simulated episcleral plaque brachytherapy in the same cohort of 10 patients (11 eyes) with DCH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>A single institutional retrospective review of patients with Sturge\u2013Weber syndrome associated DCH managed with IMRT (20 Gy in 10 fractions). Those same patients were planned for simulated brachytherapy and simulated doses to the fovea, disc, and lens were collected. The dose to organs at risk (critical visual and surrounding structures) was compared to determine potential long-term risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Ten patients (11 eyes) examined in this review were treated between 2005 and 2023. The use of IMRT and 3D allowed for effective coverage of the planning target volume (PTV) with low doses to critical visual and surrounding structures. Doses to the fovea, disc, and lens using external beam radiotherapy (EBRT) were uniform ranging from 1784 to 2151 cGy, 1695\u20132204 cGy, and 260\u20131579 cGy, respectively. Doses to the fovea, disc, and lens using episcleral plaque brachytherapy had ranged from 270 to 12270 cGy, 20623829 cGy, and 270\u2013618 cGy, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>IMRT and 3D-conformal technique used to deliver 20 Gy in 10 fractions provides a uniform safe plan in patients with DCHs with reasonable sparing of the lens, fovea, and optic disc. Simulated brachytherapy yielded variable radiation exposure to critical visual and surrounding structures with potential risk of vision-threatening toxicity. Use of EBRT or brachytherapy should be considered on a case-by-case basis driven by estimated radiation dosimetric parameters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-24-00154","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T06:05:53Z","timestamp":1742450753000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Diffuse choroidal hemangioma: IMRT versus episcleral plaque brachytherapy"],"prefix":"10.4103","volume":"15","author":[{"given":"Adannia","family":"Ufondu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackery","family":"Oakey","sequence":"additional","affiliation":[{"name":"Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"Blue Coast Retina, Hoag Memorial Hospital Presbyterian, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Cijin","family":"Puthussery","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheen","family":"Cherian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"R1-20250320","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.ophtha.2013.07.058","article-title":"Diffuse choroidal hemangioma management with plaque radiotherapy in 5 cases","volume":"120","author":"Arepalli","year":"2013","journal-title":"Ophthalmology"},{"key":"R2-20250320","doi-asserted-by":"crossref","first-page":"e29925","DOI":"10.1002\/pbc.29925","article-title":"Low-dose proton radiotherapy for pediatric choroidal hemangioma:A case series","volume":"69","author":"Franco","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000260226","article-title":"Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas","volume":"224","author":"Chan","year":"2010","journal-title":"Ophthalmologica"},{"key":"R4-20250320","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00417-015-3061-8","article-title":"Management of diffuse choroidal hemangioma in sturge-weber syndrome with ruthenium-106 plaque radiotherapy","volume":"253","author":"Kubicka-Trz\u0105ska","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-20250320","first-page":"785686","article-title":"Ruthenium-106 plaque therapy for diffuse choroidal hemangioma in sturge-weber syndrome","volume":"2011","author":"Kubicka-Trz\u0105ska","year":"2011","journal-title":"Case Rep Ophthalmol Med"},{"key":"R6-20250320","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41433-018-0024-4","article-title":"Results of external beam radiotherapy for diffuse choroidal hemangiomas in sturge-weber syndrome","volume":"32","author":"Randon","year":"2018","journal-title":"Eye (Lond)"},{"key":"R7-20250320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bjo.81.4.267","article-title":"Long-term results after low dose ocular irradiation for choroidal haemangiomas","volume":"81","author":"Schilling","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R8-20250320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18240\/ijo.2020.03.22","article-title":"Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma in sturge-weber syndrome","volume":"13","author":"Yu","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"R9-20250320","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1088\/0031-9155\/59\/6\/R183","article-title":"Advances in kilovoltage x-ray beam dosimetry","volume":"59","author":"Hill","year":"2014","journal-title":"Phys Med Biol"},{"key":"R10-20250320","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/CMAR.S351744","article-title":"Technological advancements in External Beam Radiation Therapy (EBRT):An indispensable tool for cancer treatment","volume":"14","author":"Koka","year":"2022","journal-title":"Cancer Manag Res"},{"key":"R11-20250320","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00006982-199111040-00004","article-title":"Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal detachment","volume":"11","author":"Scott","year":"1991","journal-title":"Retina"},{"key":"R12-20250320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/11206721241257974","article-title":"Ruthenium-106 ((106) Ru) plaque brachytherapy for treatment of circumscribed choroidal hemangioma","volume":"35","author":"Bajpai","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"R14-20250320","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0002-9394(14)70584-7","article-title":"Cobalt-60 treatment of choroidal hemangiomas","volume":"121","author":"Zografos","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R15-20250320","doi-asserted-by":"crossref","first-page":"870921","DOI":"10.1155\/2010\/870921","article-title":"Sedation and anesthesia options for pediatric patients in the radiation oncology suite","volume":"2010","author":"Harris","year":"2010","journal-title":"Int J Pediatr"},{"key":"R17-20250320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002820-199310000-00006","article-title":"Acute and long-term effects of radiation therapy to the eye in children","volume":"16","author":"Servodidio","year":"1993","journal-title":"Cancer Nurs"},{"key":"R18-20250320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0420.2006.00822.x","article-title":"Ophthalmic and adnexal complications of radiotherapy","volume":"85","author":"Durkin","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R19-20250320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-8140(95)01670-8","article-title":"Probable risk of tumour induction after retro-orbital irradiation for Graves'ophthalmopathy","volume":"38","author":"Snijders-Keilholz","year":"1996","journal-title":"Radiother Oncol"},{"key":"R20-20250320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000070050","article-title":"The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves'orbitopathy","volume":"35","author":"Akmansu","year":"2003","journal-title":"Ophthalmic Res"},{"key":"R21-20250320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0167-8140(99)00118-8","article-title":"Assessment of a carcinogenic risk for treatment of Graves'ophthalmopathy in dependence on age and irradiation geometry","volume":"53","author":"Broerse","year":"1999","journal-title":"Radiother Oncol"},{"key":"R22-20250320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","article-title":"A long-term follow-up study after retro-orbital irradiation for Graves'ophthalmopathy","volume":"52","author":"Schaefer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:51:44Z","timestamp":1786647104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00154","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-11-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}